National Research (NASDAQ:NRC) Stock Price Passes Above 200 Day Moving Average – Time to Sell?

National Research Corporation (NASDAQ:NRC) shares crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $17.91 and traded as high as $22.65. National Research shares last traded at $22.34, with a volume of 136,814 shares changing hands.

Analyst Upgrades and Downgrades

Several research firms have issued reports on NRC. Citizens Jmp began coverage on shares of National Research in a research report on Monday, June 22nd. They issued a “market outperform” rating and a $23.00 price objective for the company. Weiss Ratings raised shares of National Research from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, May 29th. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, National Research has an average rating of “Moderate Buy” and an average target price of $23.00.

National Research Stock Up 3.6%

The company has a current ratio of 0.52, a quick ratio of 0.52 and a debt-to-equity ratio of 5.48. The business has a 50-day moving average price of $19.00 and a 200-day moving average price of $17.91. The firm has a market cap of $508.24 million, a P/E ratio of 57.28 and a beta of 0.35.

National Research (NASDAQ:NRC) last announced its quarterly earnings results on Tuesday, April 28th. The company reported $0.21 EPS for the quarter. The firm had revenue of $34.80 million for the quarter. National Research had a return on equity of 122.73% and a net margin of 6.52%.

National Research Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 10th. Stockholders of record on Friday, June 26th will be issued a $0.16 dividend. The ex-dividend date is Friday, June 26th. This represents a $0.64 annualized dividend and a dividend yield of 2.9%. National Research’s payout ratio is currently 164.10%.

Hedge Funds Weigh In On National Research

Several institutional investors have recently bought and sold shares of NRC. M&T Bank Corp lifted its holdings in National Research by 6.4% during the second quarter. M&T Bank Corp now owns 13,608 shares of the company’s stock worth $229,000 after buying an additional 823 shares during the period. Sei Investments Co. boosted its position in National Research by 1.2% during the 3rd quarter. Sei Investments Co. now owns 76,270 shares of the company’s stock valued at $975,000 after acquiring an additional 900 shares in the last quarter. Russell Investments Group Ltd. increased its holdings in shares of National Research by 85.6% in the 3rd quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock valued at $26,000 after acquiring an additional 921 shares during the period. Invesco Ltd. increased its holdings in shares of National Research by 6.3% in the 2nd quarter. Invesco Ltd. now owns 17,368 shares of the company’s stock valued at $292,000 after acquiring an additional 1,022 shares during the period. Finally, Alliancebernstein L.P. raised its position in shares of National Research by 6.3% in the 3rd quarter. Alliancebernstein L.P. now owns 18,499 shares of the company’s stock worth $236,000 after acquiring an additional 1,100 shares in the last quarter. 47.26% of the stock is owned by hedge funds and other institutional investors.

About National Research

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.